Search Results

There are 26077 results for: content related to: Absence of Food Effect on the Pharmacokinetics of Telbivudine Following Oral Administration in Healthy Subjects

  1. Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy

    Liver Transplantation

    Volume 21, Issue 8, August 2015, Pages: 1066–1075, Ilker Turan, Suna Yapali, Fikret Bademkiran, Timur Kose, Soner Duman, Murat Sozbilen, Fulya Gunsar, Galip Ersoz, Ulus Salih Akarca, Omer Ozutemiz and Zeki Karasu

    Version of Record online : 23 JUN 2015, DOI: 10.1002/lt.24131

  2. Absence of Effect of Telbivudine on Cardiac Repolarization: Results of a Thorough QT/QTc Study in Healthy Participants

    The Journal of Clinical Pharmacology

    Volume 49, Issue 12, December 2009, Pages: 1436–1446, Dr Fred Poordad, Dr Gillian Zeldin, Dr Stuart I. Harris, Dr June Ke, Dr Limin Xu, Dr Douglas Mayers and Dr Xiao-Jian Zhou

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009337943

  3. Population Pharmacokinetics of Telbivudine and Determination of Dose Adjustment for Patients With Renal Impairment

    The Journal of Clinical Pharmacology

    Volume 49, Issue 6, June 2009, Pages: 725–734, Dr Xiao-Jian Zhou, Dr June Ke, Dr William M. Sallas, Dr Colm Farrell, Dr Douglas L. Mayers and Dr Helen S. Pentikis

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009333555

  4. Telbivudine treatment in chronic hepatitis B: experience from China

    Journal of Viral Hepatitis

    Volume 20, Issue s1, April 2013, Pages: 3–8, H. You and J. Jia

    Version of Record online : 4 MAR 2013, DOI: 10.1111/jvh.12058

  5. Single-Dose and Multiple-Dose Pharmacokinetics and Safety of Telbivudine After Oral Administration in Healthy Chinese Subjects

    The Journal of Clinical Pharmacology

    Volume 46, Issue 9, September 2006, Pages: 999–1007, Dr Pei Hu, Dr Ji Jiang, Dr Hongyun Wang, Mr Keith Pietropaolo, Dr George C. Chao, Dr Nathaniel A. Brown and Dr Xiao-Jian Zhou

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006290623

  6. Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine

    Liver International

    Volume 31, Issue 5, May 2011, Pages: 667–675, Rifaat Safadi, Qing Xie, Yagang Chen, You-Kuan Yin, Lai Wei, Seong Gyu Hwang, Eli Zuckerman, Ji-Dong Jia and Patricia Lopez

    Version of Record online : 29 OCT 2010, DOI: 10.1111/j.1478-3231.2010.02360.x

  7. Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver disease

    Journal of Viral Hepatitis

    Volume 22, Issue 7, July 2015, Pages: 574–580, E. Cholongitas, T. Vasiliadis, I. Goulis, I. Fouzas, N. Antoniadis, V. Papanikolaou and E. Akriviadis

    Version of Record online : 11 NOV 2014, DOI: 10.1111/jvh.12362

  8. Impact of nucleos(t)ide analogues on the estimated glomerular filtration rate in patients with chronic hepatitis B: a prospective cohort study in China

    Journal of Viral Hepatitis

    Volume 22, Issue 1, January 2015, Pages: 46–54, X. Qi, J.-Y Wang, R.-C Mao and J.-M Zhang

    Version of Record online : 13 FEB 2014, DOI: 10.1111/jvh.12229

  9. Continuous venovenous hemodiafiltration for hyperlactatemia caused by telbivudine in a patient with chronic hepatitis B: A case report and update review

    Journal of Digestive Diseases

    Volume 16, Issue 3, March 2015, Pages: 164–167, Yan Hong Wang, Ben Quan Wu and Hui Liu

    Version of Record online : 27 MAR 2015, DOI: 10.1111/1751-2980.12173

  10. Telbivudine treatment is associated with high hepatitis B e antigen seroconversion and immune modulatory effects in chronic hepatitis B patients

    Journal of Viral Hepatitis

    Volume 20, Issue s1, April 2013, Pages: 9–17, G.-Q. Wang, Y.-P. Ding and Y.-H. Dong

    Version of Record online : 4 MAR 2013, DOI: 10.1111/jvh.12059

  11. You have full text access to this OnlineOpen article
    Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 20, Issue 4, April 2013, Pages: e37–e46, Y. Wang, S. Thongsawat, E. J. Gane, Y.-F. Liaw, J. Jia, J. Hou, H. L. Y. Chan, G. Papatheodoridis, M. Wan, J. Niu, W. Bao, A. Trylesinski and N. V. Naoumov

    Version of Record online : 27 DEC 2012, DOI: 10.1111/jvh.12025

  12. You have free access to this content
    A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match–control study

    Clinical Microbiology and Infection

    Volume 20, Issue 2, February 2014, Pages: O90–O100, M.-C. Tsai, C.-H. Chen, C.-H. Hung, C.-M. Lee, K.-W. Chiu, J.-H. Wang, S.-N. Lu, P.-L. Tseng, K.-C. Chang, Y.-H. Yen and T.-H. Hu

    Version of Record online : 10 MAY 2013, DOI: 10.1111/1469-0691.12220

  13. You have free access to this content
    Telbivudine preserves T-helper 1 cytokine production and downregulates programmed death ligand 1 in a mouse model of viral hepatitis

    Journal of Viral Hepatitis

    Volume 17, Issue s1, March 2010, Pages: 24–33, Z. G. Wu, W. M. Yan, W. Guo, T. Chen, Y. Zou, H. W. Wang, X. J. Wang, X. J. Yang, Y. L. Lu, X. P. Luo and Q. Ning

    Version of Record online : 3 MAR 2010, DOI: 10.1111/j.1365-2893.2010.01268.x

  14. Telbivudine therapy may shape CD4+ T-cell response to prevent liver fibrosis in patients with chronic hepatitis B

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 834–845, Jing Li, Minglei Jia, Yun Liu, Weimin She, Lei Li, Jiyao Wang and Wei Jiang

    Version of Record online : 1 JUN 2014, DOI: 10.1111/liv.12589

  15. You have free access to this content
    Cost-Effectiveness of Nucleoside Analog Therapy for Hepatitis B in China: A Markov Analysis

    Value in Health

    Volume 13, Issue 5, August 2010, Pages: 592–600, Bin Wu, Te Li, Huafeng Chen and Jinfang Shen

    Version of Record online : 30 APR 2010, DOI: 10.1111/j.1524-4733.2010.00733.x

  16. You have free access to this content
    Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial

    Hepatology

    Volume 47, Issue 2, February 2008, Pages: 447–454, Jinlin Hou, You-Kuan Yin, Daozhen Xu, Deming Tan, Junqi Niu, Xiaqiu Zhou, Yuming Wang, Limin Zhu, Yongwen He, Hong Ren, Mobin Wan, Chengwei Chen, Shanming Wu, Yagang Chen, Jiazhang Xu, Qinhuan Wang, Lai Wei, George Chao, Barbara Fielman Constance, George Harb, Nathaniel A. Brown and Jidong Jia

    Version of Record online : 13 DEC 2007, DOI: 10.1002/hep.22075

  17. Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis

    Journal of Viral Hepatitis

    Volume 19, Issue 10, October 2012, Pages: 732–743, H. L.Y. Chan, Y. C. Chen, E. J. Gane, S. K. Sarin, D. J. Suh, T. Piratvisuth, B. Prabhakar, S. G. Hwang, G. Choudhuri, R. Safadi, T. Tanwandee, A. Chutaputti, C. Yurdaydin, W. Bao, C. Avila and A. Trylesinski

    Version of Record online : 15 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01600.x

  18. You have free access to this content
    The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: A randomized, controlled study

    Hepatology

    Volume 59, Issue 4, April 2014, Pages: 1283–1292, Jian Sun, Qing Xie, Deming Tan, Qin Ning, Junqi Niu, Xuefan Bai, Rong Fan, Shijun Chen, Jun Cheng, Yanyan Yu, Hao Wang, Min Xu, Guangfeng Shi, Mobin Wan, Xinyue Chen, Hong Tang, Jifang Sheng, Xiaoguang Dou, Junping Shi, Hong Ren, Maorong Wang, Hongfei Zhang, Zhiliang Gao, Chengwei Chen, Hong Ma, Jidong Jia and Jinlin Hou

    Version of Record online : 28 FEB 2014, DOI: 10.1002/hep.26885

  19. You have free access to this content
    HBV Trials and Treatments

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 647A–705A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26856

  20. Forty-eight-week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B-related cirrhosis

    Journal of Viral Hepatitis

    Volume 20, Issue s1, April 2013, Pages: 58–64, Z. Han, Y. Shi, J. Zhu, Y. Chen, F. Yin, L. Xia, G. Luo, Z. Gao, J. Liu, G. Jia, C. Li, X. Zhou and Y. Han

    Version of Record online : 4 MAR 2013, DOI: 10.1111/jvh.12065